Federation des caisses Desjardins du Quebec’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-109
Closed -$4.8K 2627
2021
Q2
$4.8K Hold
109
﹤0.01% 2252
2021
Q1
$7.94K Buy
+109
New +$7.74K ﹤0.01% 2064

Other funds holding ORTX

Federation des caisses Desjardins du Quebec's ORTX Position: Q3 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 109 shares — an estimated $4.8K sold.

Federation des caisses Desjardins du Quebec first reported a position in ORTX in Q1 2021 and held it in 2 quarters. The position peaked at $7.94K in Q1 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

  • Federation des caisses Desjardins du Quebec reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 109 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $4.8K.
  • Federation des caisses Desjardins du Quebec first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Federation des caisses Desjardins du Quebec's Orchard Therapeutics plc American Depositary Shares position peaked at $7.94K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2021, filed 30 Aug 2024.